The Latest Breaking News from Food and Drug Administration

A coalition of state attorneys general is suing the Food and Drug Administration over its regulation of mifepristone. NPR's Michel Martin speaks with Washington state Attorney General Bob Ferguson.

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine.

The Food and Drug Administration is pledging a reset in the agency’s tobacco program

The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs.

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation

The bottles of Starbucks' vanilla Frappuccinos may contain pieces of glass, the Food and Drug Administration said.

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. Even if approved, the medication may not reach many people who need it.

Florida’s top health official sent a letter this week to the heads of the Food and Drug Administration and the Centers for Disease Control and Prevention warning that mRNA COVID-19 vaccines could be dangerous.